Quality Prescribing Strategy for Respiratory: A Guide for Improvement 2024-2027
(2024)
Report
Anderson, D., Fardon, T., Mair, A., Korsah, P., Smith, G., Strath, A., McMahon, A., & Leitch, J. (2024). Quality Prescribing Strategy for Respiratory: A Guide for Improvement 2024-2027
All Outputs (4)
Type 2 Diabetes Mellitus - quality prescribing strategy: improvement guide 2024 to 2027 (2024)
Report
Mair, A., Kennon, B., Chalmers, J., Smith, G., Strath, A., McMahon, A., & Leitch, J. (2024). Type 2 Diabetes Mellitus - quality prescribing strategy: improvement guide 2024 to 2027. Scottish GovernmentThis quality prescribing guide is intended to support clinicians across the multidisciplinary team and people with Type 2 Diabetes Mellitus (T2DM) in shared decision-making and the effective use of medicines, and offers practical advice and options f... Read More about Type 2 Diabetes Mellitus - quality prescribing strategy: improvement guide 2024 to 2027.
Global burden of preventable medication-related harm in health care: a systematic review (2023)
Report
Panagioti, M., Hodkinson, A., Planner, C., Dhingra, N., & Gupta, N. (2023). Global burden of preventable medication-related harm in health care: a systematic review. Geneva: World Health Organization
Evidence of the Impact of Interventions to Decrease Polypharmacy (2023)
Book Chapter
Mair, A. (2023). Evidence of the Impact of Interventions to Decrease Polypharmacy. In Encyclopaedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy. Springer. https://doi.org/10.1007/978-3-030-50247-8_146-1As many as 50% of all patients with long-term conditions are using their medicines in a way that is not fully effective. This results in suboptimal treatment of their condition and attendance or admission to hospital. There is a significant level of... Read More about Evidence of the Impact of Interventions to Decrease Polypharmacy.